Inspiringly, we found that lean NAFLD subjects shared similar risks of metabolic factors, including fasting glucose, insulin resistance, lipid profiles, and blood pressure, with non-lean, non-NAFLD subjects. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.